Cargando…
Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances
SIMPLE SUMMARY: Immunotherapy has changed the landscape of treatment modalities available for many different types of malignancies. However, the factors that influence the success of immunotherapeutics have not been as clearly seen in advanced prostate cancer, likely due to immunosuppressive factors...
Autores principales: | Movassaghi, Miyad, Chung, Rainjade, Anderson, Christopher B., Stein, Mark, Saenger, Yvonne, Faiena, Izak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507531/ https://www.ncbi.nlm.nih.gov/pubmed/34638243 http://dx.doi.org/10.3390/cancers13194757 |
Ejemplares similares
-
Multimodal treatments for advanced prostate cancer
por: Faiena, Izak, et al.
Publicado: (2019) -
Prevention of erectile dysfunction after radiotherapy for prostate cancer
por: Faiena, Izak, et al.
Publicado: (2014) -
Urology Virtual Education Programs During the COVID-19 Pandemic
por: Smigelski, Michael, et al.
Publicado: (2020) -
A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
por: Sooi, Kenneth, et al.
Publicado: (2023) -
Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review)
por: FAIENA, IZAK, et al.
Publicado: (2014)